Paul Gunn
Fundador en Soricimed Biopharma, Inc. .
Cargos activos de Paul Gunn
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Soricimed Biopharma, Inc.
 Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Presidente | - | - |
| Fundador | 01/01/2005 | - | |
| Director Ejecutivo | - | 17/07/2019 |
Historial de carrera de Paul Gunn
Antiguos cargos conocidos de Paul Gunn.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Whitehill Technologies, Inc.
 Whitehill Technologies, Inc. Information Technology ServicesTechnology Services Whitehill Technologies, Inc. develops document composition and data transformation software. It develops software that accelerates business communication by automating document creation, workflow, and compliance. The company was founded in 1997 and is headquartered in Moncton, Canada. | Director Administrativo | - | - |
| Director Financiero/CFO | - | - |
Estadísticas
Internacional
| Canadá | 3 |
Operativa
| Chief Administrative Officer | 1 |
| Director of Finance/CFO | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Technology Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Whitehill Technologies, Inc.
Whitehill Technologies, Inc. Information Technology ServicesTechnology Services Whitehill Technologies, Inc. develops document composition and data transformation software. It develops software that accelerates business communication by automating document creation, workflow, and compliance. The company was founded in 1997 and is headquartered in Moncton, Canada. | Technology Services |
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Paul Gunn
- Experiencia
